Hikma Pharmaceuticals PLC Net Asset Quality Index
Hikma Pharmaceuticals PLC net asset quality index. Hikma Pharmaceuticals PLC (HIK) has a Net Asset Quality Index of 45.9% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX5.55 Billion minus total liabilities of GBX3.00 Billion yields net assets of GBX2.55 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Hikma Pharmaceuticals PLC cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hikma Pharmaceuticals PLC (2002–2024)
Net asset quality index of Hikma Pharmaceuticals PLC from 2002 to 2024. This chart shows how Hikma Pharmaceuticals PLC's Net Asset Quality Index has evolved across 23 annual periods from 2002 to 2024. As of June 2025, the index stands at 45.9%, representing net assets of GBX2.55 Billion against total assets of GBX5.55 Billion GBX. See net assets of Hikma Pharmaceuticals PLC for net asset value and shareholders' equity analysis.
Hikma Pharmaceuticals PLC Net Asset Quality Index by Year (2002–2024)
Hikma Pharmaceuticals PLC net asset quality index by year from 2002 to 2024. The table below presents the year-by-year Net Asset Quality Index for Hikma Pharmaceuticals PLC from 2002 to 2024, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see HIK market cap.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 45.2% | GBX2.32 Billion | GBX5.13 Billion | GBX2.81 Billion | ▼ -2.0 pp |
| 2023 | 47.2% | GBX2.21 Billion | GBX4.68 Billion | GBX2.47 Billion | ▼ -0.8 pp |
| 2022 | 48.0% | GBX2.15 Billion | GBX4.47 Billion | GBX2.32 Billion | ▼ -8.4 pp |
| 2021 | 56.4% | GBX2.47 Billion | GBX4.37 Billion | GBX1.91 Billion | ▲ +4.5 pp |
| 2020 | 51.9% | GBX2.15 Billion | GBX4.13 Billion | GBX1.99 Billion | ▼ -2.2 pp |
| 2019 | 54.2% | GBX2.13 Billion | GBX3.93 Billion | GBX1.80 Billion | ▲ +5.6 pp |
| 2018 | 48.5% | GBX1.70 Billion | GBX3.50 Billion | GBX1.80 Billion | ▲ +3.4 pp |
| 2017 | 45.1% | GBX1.53 Billion | GBX3.39 Billion | GBX1.86 Billion | ▼ -10.2 pp |
| 2016 | 55.3% | GBX2.41 Billion | GBX4.36 Billion | GBX1.95 Billion | ▲ +3.2 pp |
| 2015 | 52.1% | GBX1.35 Billion | GBX2.60 Billion | GBX1.25 Billion | ▼ -2.0 pp |
| 2014 | 54.0% | GBX1.22 Billion | GBX2.25 Billion | GBX1.03 Billion | ▲ +0.4 pp |
| 2013 | 53.6% | GBX1.03 Billion | GBX1.93 Billion | GBX895.00 Million | ▲ +4.6 pp |
| 2012 | 49.0% | GBX847.85 Million | GBX1.73 Billion | GBX882.26 Million | ▼ -1.7 pp |
| 2011 | 50.7% | GBX798.63 Million | GBX1.58 Billion | GBX777.01 Million | ▼ -16.6 pp |
| 2010 | 67.2% | GBX750.30 Million | GBX1.12 Billion | GBX365.52 Million | ▲ +0.4 pp |
| 2009 | 66.8% | GBX683.26 Million | GBX1.02 Billion | GBX339.46 Million | ▲ +3.8 pp |
| 2008 | 63.0% | GBX609.00 Million | GBX966.46 Million | GBX357.46 Million | ▲ +15.5 pp |
| 2007 | 47.5% | GBX424.66 Million | GBX894.04 Million | GBX469.38 Million | ▼ -24.1 pp |
| 2006 | 71.6% | GBX349.80 Million | GBX488.36 Million | GBX138.56 Million | ▼ -0.6 pp |
| 2005 | 72.2% | GBX287.48 Million | GBX397.96 Million | GBX110.48 Million | ▲ +13.3 pp |
| 2004 | 58.9% | GBX145.18 Million | GBX246.48 Million | GBX101.31 Million | ▲ +7.6 pp |
| 2003 | 51.3% | GBX60.47 Million | GBX117.86 Million | GBX57.39 Million | ▲ +0.7 pp |
| 2002 | 50.6% | GBX48.03 Million | GBX94.86 Million | GBX46.84 Million | — |